title: Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Moroni
authors.forename: Beniamina
authors.initials: B
authors.lastname: Gallelli
authors.forename: Renato Alberto
authors.initials: RA
authors.lastname: Sinico
authors.forename: Giulio
authors.initials: G
authors.lastname: Romano
authors.forename: Luigi
authors.initials: L
authors.lastname: Sinigaglia
authors.forename: Piergiorgio
authors.initials: P
authors.lastname: Messa
mesh_terms: D000284:Administration, Oral; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D003520:Cyclophosphamide